3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors
- 15 February 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (4) , 1033-1036
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- 3,4-Dihydro-2H-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activityBioorganic & Medicinal Chemistry Letters, 2005
- Latency to paroxetine‐induced anxiolysis in the rat is reduced by co‐administration of the 5‐HT1A receptor antagonist WAY100635British Journal of Pharmacology, 2000
- A Double-blind, Randomized, Placebo-Controlled Trial of Pindolol Augmentation in Depressive Patients Resistant to Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1999
- Does the Addition of Pindolol Accelerate or Enhance the Response to Selective Serotonin Reuptake Inhibitor Antidepressants?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disordersBiological Psychiatry, 1998
- How Long Should Pindolol Be Associated With Paroxetine to Improve the Antidepressant Response?Journal of Clinical Psychopharmacology, 1997
- Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindololJournal of Affective Disorders, 1997
- Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatmentThe Lancet, 1997
- The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brainNeuroscience Letters, 1996
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994